Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Other alimentary tract and metabolism products

Vimizim

(elosulfase alfa)

Uses, side effects, dosage information & price range

BioMarin International Limited

About this medicine

Vimizim is indicated for the treatment of mucopolysaccharidosis, type IVA (Morquio A Syndrome, MPS IVA) in patients of all ages.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

UcedaneComposition: carglumic acidEurocept International BV

Price on RequestView Details →

SephienceComposition: sepiapterinPTC Therapeutics International Limited

Price on RequestView Details →

CerdelgaComposition: eliglustatSanofi B.V.

Price on RequestView Details →

ProcysbiComposition: mercaptamineChiesi Farmaceutici S.p.A

Price on RequestView Details →

Sapropterin DipharmaComposition: sapropterinDipharma Arzneimittel GmbH

Price on RequestView Details →

Key Information

Salt / Composition

elosulfase alfa

Category

Other alimentary tract and metabolism products

Manufacturer

BioMarin International Limited

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.